Insmed Inc. buy JPMorgan Chase & Co.
Start price
20.08.25
/
50%
€110.00
Target price
20.08.26
€116.07
Performance (%)
-2.62%
End price
02:15
-
Summary
This prediction is currently being closed. With a performance of -2.62%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. JPMorgan_Chase___Co_ has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 1.985% | 1.985% | 0.901% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $111.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten